{"name":"Jiaxing AnDiCon Biotech Co.,Ltd","slug":"jiaxing-andicon-biotech-co-ltd","ticker":"","exchange":"","domain":"","description":"Jiaxing AnDiCon Biotech Co., Ltd is a biotechnology company focused on the development and commercialization of innovative pharmaceutical products. The company has a pipeline of 11 drugs, with a strong emphasis on antiviral therapies, including Baloxavir Marboxil tablets in Phase 3 trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":6,"colorKey":"oncology","drugs":[{"name":"Baloxavir Marboxil tablets","genericName":"Baloxavir Marboxil tablets","slug":"baloxavir-marboxil-tablets","indication":"Acute uncomplicated influenza (treatment)","status":"phase_3"},{"name":"ADC-189 and Itraconazole","genericName":"ADC-189 and Itraconazole","slug":"adc-189-and-itraconazole","indication":"Other","status":"phase_1"},{"name":"ADC189 180mg","genericName":"ADC189 180mg","slug":"adc189-180mg","indication":"Other","status":"phase_1"},{"name":"Placebo of ADC189 granules","genericName":"Placebo of ADC189 granules","slug":"placebo-of-adc189-granules","indication":"Other","status":"phase_3"},{"name":"Placebo of ADC189 tablets","genericName":"Placebo of ADC189 tablets","slug":"placebo-of-adc189-tablets","indication":"Other","status":"phase_3"},{"name":"Placebo of Baloxavir Marboxil tablets","genericName":"Placebo of Baloxavir Marboxil tablets","slug":"placebo-of-baloxavir-marboxil-tablets","indication":"Control arm in Phase 3 clinical trials of Baloxavir Marboxil for influenza treatment or prophylaxis","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"ADC189 tablet","genericName":"ADC189 tablet","slug":"adc189-tablet","indication":"Solid tumors (specific indication under investigation in phase 3)","status":"phase_3"},{"name":"ADC189 tablets","genericName":"ADC189 tablets","slug":"adc189-tablets","indication":"Solid tumors (specific indication under investigation in Phase 3)","status":"phase_3"}]}],"pipeline":[{"name":"Baloxavir Marboxil tablets","genericName":"Baloxavir Marboxil tablets","slug":"baloxavir-marboxil-tablets","phase":"phase_3","mechanism":"Baloxavir marboxil inhibits the influenza virus endonuclease, blocking viral cap-dependent transcription and preventing viral replication.","indications":["Acute uncomplicated influenza (treatment)","Influenza prophylaxis"],"catalyst":""},{"name":"ADC-189 and Itraconazole","genericName":"ADC-189 and Itraconazole","slug":"adc-189-and-itraconazole","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ADC189 180mg","genericName":"ADC189 180mg","slug":"adc189-180mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ADC189 tablet","genericName":"ADC189 tablet","slug":"adc189-tablet","phase":"phase_3","mechanism":"ADC189 is an antibody-drug conjugate that targets a specific tumor-associated antigen to deliver cytotoxic payload directly to cancer cells.","indications":["Solid tumors (specific indication under investigation in phase 3)"],"catalyst":""},{"name":"ADC189 tablets","genericName":"ADC189 tablets","slug":"adc189-tablets","phase":"phase_3","mechanism":"ADC189 is an antibody-drug conjugate that targets a specific tumor-associated antigen to deliver cytotoxic payload directly to cancer cells.","indications":["Solid tumors (specific indication under investigation in Phase 3)"],"catalyst":""},{"name":"Placebo of ADC189 granules","genericName":"Placebo of ADC189 granules","slug":"placebo-of-adc189-granules","phase":"phase_3","mechanism":"This is a placebo control formulation used in clinical trials and contains no active pharmaceutical ingredient.","indications":[],"catalyst":""},{"name":"Placebo of ADC189 tablets","genericName":"Placebo of ADC189 tablets","slug":"placebo-of-adc189-tablets","phase":"phase_3","mechanism":"This is a placebo control formulation used in clinical trials and contains no active pharmaceutical ingredient.","indications":[],"catalyst":""},{"name":"Placebo of Baloxavir Marboxil tablets","genericName":"Placebo of Baloxavir Marboxil tablets","slug":"placebo-of-baloxavir-marboxil-tablets","phase":"phase_3","mechanism":"This is a placebo control formulation with no active pharmacological mechanism.","indications":["Control arm in Phase 3 clinical trials of Baloxavir Marboxil for influenza treatment or prophylaxis"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":8,"phaseCounts":{"phase_3":6,"phase_1":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}